Sept 30 (Reuters) - Acasti Pharma Inc ACST.V :
* ACASTI PHARMA ANNOUNCES ADDITIONAL PHASE 3 MILESTONES REACHED, AND REMAINS ON TRACK TO REPORT TOPLINE RESULTS FOR TRILOGY 1 IN DECEMBER 2019 AND TRILOGY 2 IN JANUARY 2020
* ACASTI PHARMA INC - CO CURRENTLY EXPECTS THAT TOPLINE RESULTS WILL NOT INCLUDE ANY SECONDARY OR EXPLORATORY ENDPOINTS